Nonadherence to dual antiplatelet therapy: old problems without new solutions

Rev Esp Cardiol (Engl Ed). 2024 Feb;77(2):125-128. doi: 10.1016/j.rec.2023.08.003. Epub 2023 Sep 1.

[Article in English, Spanish]

Authors

Luis Ortega-Paz¹, Roxana Mehran², Dominick J Angiolillo³

Affiliations

¹ Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States.
² The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, United States.
³ Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States. Electronic address: dominick.angiolillo@jax.ufl.edu.

PMID: 37659651
DOI: 10.1016/j.rec.2023.08.003

No abstract available

MeSH terms

Aspirin* / therapeutic use
Clopidogrel
Drug Therapy, Combination
Humans
Platelet Aggregation Inhibitors* / therapeutic use

Substances

Platelet Aggregation Inhibitors
Aspirin
Clopidogrel